press release

Reminder re: COVID-19 Vaccine Second Dose Appointments

Point Edward, ON – Based on a decision by the Provincial Government in March, COVID-19 vaccination intervals have been extended from four weeks to 16 weeks for three vaccines (Moderna, Pfizer & AstraZeneca).

“This means if your second dose appointment was scheduled four weeks after your first dose (or if you did not receive an additional appointment), your second dose booking needs to be re-scheduled,” said Kevin Churchill, Manager of Family Health. “The new appointment will be 16 weeks after your first dose.”

Second dose appointments for these groups are expected to begin starting in June 2021.

“A few weeks ago, we reached out to the majority of residents who needed to have their second dose appointments re-scheduled,” said Kevin. “We also distributed two news releases and several social media posts, but unfortunately, we heard reports this weekend that some individuals went to the Point Edward clinic to get their second doses, and found the facility was closed. We are incredibly sorry for any inconvenience this may have caused, and will be in touch to schedule your second dose appointments as soon as possible.”

Lambton Public Health will contact you directly with an appointment booking option. Please do not call or request your second dose appointment at this time. The health unit is in the process of securing appointment options for this group under a new set of dates. Please do not attend a clinic expecting to receive your vaccination unless you have an appointment booked.

Note: If you booked your COVID-19 vaccination appointment using the Provincial Booking System, your first and second dose appointments were scheduled using the new 16 week interval. Your appointment is still confirmed, and no further action is required.

Please visit for the latest COVID-19 related updates in Lambton County. If you have specific questions related to the vaccination registration process please check out our Frequently Asked Questions page.

Please contact:

Comments are closed.